N Engl J Med.
1987 Nov 12;317(20):1246-51.
Effects on infants of a first episode of genital herpes during pregnancy.
Brown ZA, Vontver LA, Benedetti J, Critchlow CW, Sells CJ, Berry S, Corey L.
Department of Obstetrics and Gynecology, University of Washington, Seattle
98195.
Although genital herpes simplex virus (HSV) infections occurring during
pregnancy are known to be associated with neonatal and maternal complications,
their frequency and contributing risk factors are not well understood. We
prospectively followed 29 patients who acquired genital herpes during pregnancy,
to evaluate the perinatal effects of the infection. The patients were classified
on the basis of clinical or serologic criteria. Fifteen patients had a primary
first episode of genital HSV Type 2 (HSV-2), and 14 had a nonprimary first
episode. Although no patient had disseminated disease, 6 of the 15 with primary
genital herpes but none of 14 with nonprimary first-episode infection had
infants with serious perinatal morbidity (P less than 0.01). Four of the five
infants whose mothers acquired primary HSV-2 in the third trimester had
perinatal morbidity such as prematurity, intrauterine growth retardation, and
neonatal infection with HSV-2. Perinatal complications occurred in one of five
infants whose mothers acquired primary HSV-2 during the first trimester, as well
as in one of five infants whose mothers had primary HSV-2 during the second
trimester. Asymptomatic cervical shedding of HSV-2 was detected at 10.6 percent
of weekly visits made after a primary first episode, as compared with 0.5
percent of visits after a nonprimary first episode (P less than 0.01). We
conclude that infants born to women who acquire primary genital herpes during
pregnancy are at high risk of exposure to HSV, either during premature labor at
the time of the primary episode or subsequently because of asymptomatic cervical
shedding of the virus. The 40 percent incidence of serious perinatal morbidity
in such women suggests that studies of preventive measures such as the use of
antiviral chemotherapy are warranted.